NovaBiotics Ltd has been awarded a £220,000 grant through a Knowledge Transfer Partnership in partnership with Aberdeen University.
The majority of the funding will be used to further the development of Novamycintm (NP339) for the treatment of life threatening yeast and fungal infections.
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
Sign up for the Funding Newswire
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.
